550 related articles for article (PubMed ID: 17456574)
1. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
2. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
[TBL] [Abstract][Full Text] [Related]
4. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
Magnisali P; Chalioti MB; Livadara T; Mataragas M; Paliatsiou S; Malamitsi-Puchner A; Moutsatsou P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1565-72. PubMed ID: 21514253
[TBL] [Abstract][Full Text] [Related]
6. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
[TBL] [Abstract][Full Text] [Related]
7. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
[TBL] [Abstract][Full Text] [Related]
8. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
9. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
Janzen N; Sander S; Terhardt M; Steuerwald U; Peter M; Das AM; Sander J
Steroids; 2011 Dec; 76(13):1437-42. PubMed ID: 21839763
[TBL] [Abstract][Full Text] [Related]
10. Steroid profiling for the diagnosis of congenital adrenal hyperplasia by microbore ultra-performance liquid chromatography-tandem mass spectrometry.
Feng D; Wang Z; Li H; Shi X; Zou L; Kong H; Xu Z; Yu C; Hu C; Xu G
Clin Chim Acta; 2023 Mar; 543():117304. PubMed ID: 36958425
[TBL] [Abstract][Full Text] [Related]
11. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
[TBL] [Abstract][Full Text] [Related]
12. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
[TBL] [Abstract][Full Text] [Related]
13. Determination of a steroid profile in heel prick blood using LC-MS/MS.
Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
[TBL] [Abstract][Full Text] [Related]
14. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
[TBL] [Abstract][Full Text] [Related]
15. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
Watanabe K; Tsuji-Hosokawa A; Hashimoto A; Konishi K; Ishige N; Yajima H; Sutani A; Nakatani H; Gau M; Takasawa K; Tajima T; Hasegawa T; Morio T; Kashimada K
J Clin Endocrinol Metab; 2022 Nov; 107(12):3341-3352. PubMed ID: 36071550
[TBL] [Abstract][Full Text] [Related]
16. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
[TBL] [Abstract][Full Text] [Related]
17. Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates.
Choi R; Park HD; Oh HJ; Lee K; Song J; Lee SY
Ann Lab Med; 2019 May; 39(3):263-270. PubMed ID: 30623618
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
[TBL] [Abstract][Full Text] [Related]
19. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns.
Dhillon K; Ho T; Rich P; Xu D; Lorey F; She J; Bhandal A
Clin Chim Acta; 2011 Nov; 412(23-24):2076-84. PubMed ID: 21803033
[TBL] [Abstract][Full Text] [Related]
20. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry.
Rossi C; Calton L; Hammond G; Brown HA; Wallace AM; Sacchetta P; Morris M
Clin Chim Acta; 2010 Feb; 411(3-4):222-8. PubMed ID: 19931522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
